RA CAPITAL MANAGEMENT, L.P. Q2 2019 Filing
Filed August 14, 2019
Portfolio Value
$1.9T
Holdings
25
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 4,132,442 | $475.9B | 25.54% | |
| 2 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $202.9B | 10.89% | |
| 3 | —ZOGENIX INC | 3,722,504 | $177.9B | 9.55% | |
| 4 | —RA PHARMACEUTICALS INC | 4,858,260 | $137.0B | 7.35% | |
| 5 | —SYNTHORX INC | 9,724,598 | $131.4B | 7.05% | |
| 6 | —EIDOS THERAPEUTICS INC | 2,162,671 | $112.7B | 6.05% | |
| 7 | ORTXUSDORCHARD THERAPEUTICS PLC | 5,108,330 | $71.5B | 3.84% | |
| 8 | TGTXTG THERAPEUTICS INC | 6,880,323 | $59.5B | 3.19% | |
| 9 | —MYOVANT SCIENCES LTD | 6,545,642 | $59.2B | 3.18% | |
| 10 | CRNXCRINETICS PHARMACEUTICALS INC | 1,875,209 | $46.9B | 2.52% | |
| 11 | RYTMRHYTHM PHARMACEUTICALS INC | 1,884,782 | $41.5B | 2.23% | |
| 12 | —DICERNA PHARMACEUTICALS INC | 2,456,669 | $38.7B | 2.08% | |
| 13 | ARVNARVINAS INC | 1,688,412 | $37.1B | 1.99% | |
| 14 | —PREVAIL THERAPEUTICS INC | 2,743,625 | $36.2B | 1.94% | |
| 15 | AXSMAXSOME THERAPEUTICS INC | 1,340,828 | $34.5B | 1.85% | |
| 16 | STOKSTOKE THERAPEUTICS INC | 1,119,963 | $32.7B | 1.75% | |
| 17 | KALAKALA PHARMACEUTICALS INC | 4,537,478 | $28.9B | 1.55% | |
| 18 | SWAVUSDSHOCKWAVE MED INC | 495,608 | $28.3B | 1.52% | |
| 19 | DTILPRECISION BIOSCIENCES INC | 1,842,366 | $24.4B | 1.31% | |
| 20 | SLDBSOLID BIOSCIENCES INC | 2,689,444 | $21.3B | 1.14% | |
| 21 | ALECALECTOR INC | 1,000,000 | $19.0B | 1.02% | |
| 22 | GTHXEURG1 THERAPEUTICS INC | 483,990 | $14.8B | 0.80% | |
| 23 | ASNSUSDX4 PHARMACEUTICALS INC | 861,393 | $12.9B | 0.69% | |
| 24 | SCPHSCPHARMACEUTICALS INC | 3,247,005 | $10.4B | 0.56% | |
| 25 | —ODONATE THERAPEUTICS INC | 200,000 | $7.3B | 0.39% |